| Product Code: ETC7540464 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Companion Diagnostics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Companion Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 India Companion Diagnostics Market - Industry Life Cycle |
3.4 India Companion Diagnostics Market - Porter's Five Forces |
3.5 India Companion Diagnostics Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.6 India Companion Diagnostics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 India Companion Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in India leading to a higher demand for personalized treatment options. |
4.2.2 Growing healthcare expenditure and focus on precision medicine in the Indian healthcare sector. |
4.2.3 Rising awareness among healthcare professionals and patients about the benefits of companion diagnostics. |
4.3 Market Restraints |
4.3.1 Lack of standardized regulatory framework for companion diagnostics in India. |
4.3.2 Limited access to advanced diagnostic technologies in rural areas. |
4.3.3 High cost associated with companion diagnostics impacting affordability for a larger section of the population. |
5 India Companion Diagnostics Market Trends |
6 India Companion Diagnostics Market, By Types |
6.1 India Companion Diagnostics Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 India Companion Diagnostics Market Revenues & Volume, By Technology Type, 2021- 2031F |
6.1.3 India Companion Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.1.4 India Companion Diagnostics Market Revenues & Volume, By Polymerase Chain Reaction (PCR), 2021- 2031F |
6.1.5 India Companion Diagnostics Market Revenues & Volume, By Next Generation Sequencing (NGS), 2021- 2031F |
6.1.6 India Companion Diagnostics Market Revenues & Volume, By In Situ Hybridization, 2021- 2031F |
6.1.7 India Companion Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Companion Diagnostics Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 India Companion Diagnostics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 India Companion Diagnostics Market Revenues & Volume, By Neurology, 2021- 2031F |
6.2.4 India Companion Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 India Companion Diagnostics Market Import-Export Trade Statistics |
7.1 India Companion Diagnostics Market Export to Major Countries |
7.2 India Companion Diagnostics Market Imports from Major Countries |
8 India Companion Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of companion diagnostics by healthcare facilities in India. |
8.2 Number of partnerships and collaborations between diagnostic companies and pharmaceutical firms for companion diagnostics development. |
8.3 Rate of incorporation of companion diagnostics in clinical decision-making by healthcare providers in India. |
9 India Companion Diagnostics Market - Opportunity Assessment |
9.1 India Companion Diagnostics Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.2 India Companion Diagnostics Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 India Companion Diagnostics Market - Competitive Landscape |
10.1 India Companion Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 India Companion Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here